Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label, Single-Arm Study to Evaluate Gastrointestinal Tolerability in Subjects With Relapsing-Remitting Multiple Sclerosis Receiving Dimethyl Fumarate (TOLERATE)

NCT02125604 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT02125604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02125604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label, Single-Arm Study to Evaluate Gastrointestinal Tolerability in Subjects With Relapsing-Remitting Multiple Sclerosis Receiving Dimethyl Fumarate (TOLERATE)
Lead sponsor
Biogen
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2014
Completion date
March 31, 2016
Enrollment
214 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing-remitting multiple sclerosis